Pharming (PHAR) Net Income (2020 - 2025)
Historic Net Income for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to $25.0 million.
- Pharming's Net Income rose 27524.04% to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year increase of 15647.29%. This contributed to the annual value of -$12.0 million for FY2024, which is 20512.36% down from last year.
- According to the latest figures from Q3 2025, Pharming's Net Income is $25.0 million, which was up 27524.04% from $9.4 million recorded in Q2 2025.
- Pharming's 5-year Net Income high stood at $25.6 million for Q2 2021, and its period low was -$22.5 million during Q2 2024.
- Moreover, its 5-year median value for Net Income was $3.0 million (2022), whereas its average is $1.6 million.
- In the last 5 years, Pharming's Net Income surged by 2476194.35% in 2022 and then tumbled by 22382.07% in 2023.
- Quarter analysis of 5 years shows Pharming's Net Income stood at $15.2 million in 2021, then crashed by 63.57% to $5.5 million in 2022, then crashed by 223.82% to -$6.9 million in 2023, then increased by 10.86% to -$6.1 million in 2024, then skyrocketed by 508.97% to $25.0 million in 2025.
- Its last three reported values are $25.0 million in Q3 2025, $9.4 million for Q2 2025, and -$3.9 million during Q1 2025.